India Gains Edge in US Market Under New Tariff Regime

17 Jul 2025 CW Team

The third edition of Niti Aayog’s “Trade Watch Quarterly” for Q3 of FY25 highlighted that, under the current US tariff regime at the HS 2 level, India is likely to gain competitiveness in 22 of the top 30 product categories. These categories account for 61 per cent of India’s exports to the US and 68 per cent of total US imports.

The report stated that India’s relative tariff advantage presents a timely opportunity to expand its market share in the US, particularly in sectors such as pharmaceuticals, textiles, and electrical machinery. It called for agile policymaking to make the most of shifting global trade dynamics.

In categories where India does face a slightly higher tariff burden—six out of the top 30 HS 2 product lines—the average disadvantage is only about 1 per cent, implying that India remains broadly competitive across key sectors.

The report further noted that India stands to benefit from both high-value sectors, such as electronics and nuclear reactors, as well as labour-intensive segments like apparel and textiles, thanks to realigned tariffs imposed by the US on competing nations.

The analysis assumes a baseline additional tariff of 10 per cent on imports into the US from all countries except Mexico and Canada. However, imports from Mexico and Canada face even steeper tariffs of 25 per cent and 35 per cent respectively, while those from China are subject to an additional 30 per cent tariff.

The latest tariff schedule, updated as of 10 July 2025, has been incorporated into the assessment. Notably, reciprocal tariffs of 26 per cent (including the 10 per cent base) on Indian goods have been temporarily suspended until 1 August. If a pending interim trade deal between India and the US is not concluded by then, the US may consider imposing these reciprocal duties.

The report cautioned that the global trade landscape remains fluid, with future tariff actions likely depending on negotiations and trade agreements between the US and its various partners.

India is poised to gain a strategic edge in the United States market under the evolving US trade and tariff structure, offering an advantage over competitors such as China, Canada and Mexico in key sectors like nuclear reactors, iron and steel, textiles, electricals and vehicles, according to a Niti Aayog report.The third edition of Niti Aayog’s “Trade Watch Quarterly” for Q3 of FY25 highlighted that, under the current US tariff regime at the HS 2 level, India is likely to gain competitiveness in 22 of the top 30 product categories. These categories account for 61 per cent of India’s exports to the US and 68 per cent of total US imports.The report stated that India’s relative tariff advantage presents a timely opportunity to expand its market share in the US, particularly in sectors such as pharmaceuticals, textiles, and electrical machinery. It called for agile policymaking to make the most of shifting global trade dynamics.In categories where India does face a slightly higher tariff burden—six out of the top 30 HS 2 product lines—the average disadvantage is only about 1 per cent, implying that India remains broadly competitive across key sectors.The report further noted that India stands to benefit from both high-value sectors, such as electronics and nuclear reactors, as well as labour-intensive segments like apparel and textiles, thanks to realigned tariffs imposed by the US on competing nations.The analysis assumes a baseline additional tariff of 10 per cent on imports into the US from all countries except Mexico and Canada. However, imports from Mexico and Canada face even steeper tariffs of 25 per cent and 35 per cent respectively, while those from China are subject to an additional 30 per cent tariff.The latest tariff schedule, updated as of 10 July 2025, has been incorporated into the assessment. Notably, reciprocal tariffs of 26 per cent (including the 10 per cent base) on Indian goods have been temporarily suspended until 1 August. If a pending interim trade deal between India and the US is not concluded by then, the US may consider imposing these reciprocal duties.The report cautioned that the global trade landscape remains fluid, with future tariff actions likely depending on negotiations and trade agreements between the US and its various partners.

Infrastructure Urban

10 Mar 2026

ABB to Invest Rs 6.25 Billion to Expand India Manufacturing

ABB recently announced plans to invest approximately Rs 6.25 billion ($75 million) in India during 2026 to expand its manufacturing footprint and research and development capabilities. The investment follows more than $35 million spent in 2025 and reflects the company’s continued focus on strengthening its ‘local-for-local’ strategy in the country.The investment will support ABB’s Electrification, Motion and Automation businesses and expand manufacturing capacity for infrastructure sectors such as renewable energy, metro rail, data centres and industrial applications. Approximately 300..

Equipment

10 Mar 2026

Six WOLFF Cranes Handle 60,000 m³ Concrete for German Hospital

Six WOLFF tower cranes are playing a key role in constructing a new hospital complex in Memmingen, Germany, supporting large-scale material handling for the project. The facility is being built on a 7.7-hectare site and will feature six floors, around 480 beds and a gross floor area exceeding 75,000 sq m.Building shell works began recently in February 2025. One WOLFF 6531.12 Cross crane supported early site preparation before being dismantled in autumn 2025, while five remaining cranes continue operations. Over an average deployment period of 16 months, the cranes are expected to move approxim..

Equipment

10 Mar 2026

REC Funds Rs 115.6 Million CSR Support for Bihar Eye Hospital

REC recently committed Rs 115.6 million under its Corporate Social Responsibility (CSR) programme for the procurement of clinical and non-clinical equipment at Sankara Eye Hospital in Saharsa, Bihar. The initiative aims to strengthen healthcare infrastructure and improve access to specialised eye care services in the region.A Memorandum of Agreement (MoA) was recently signed between Pradeep Fellows, Executive Director (CSR), REC Limited, and Wg Cdr V. Shankar (Retd), Trustee and Executive Director of Sankara Eye Hospital, at the REC office in the SCOPE Complex, New Delhi.The support is expecte..